In the US, Erlotinib (erlotinib systemic) is a member of the drug class EGFR inhibitors and is used to treat Non-Small Cell Lung Cancer, Pancreatic Cancer and Renal Cell Carcinoma.
US matches:
- Erlotinib
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XE03
CAS registry number (Chemical Abstracts Service)
0183321-74-6
Chemical Formula
C22-H23-N3-O4
Molecular Weight
393
Therapeutic Categories
Antineoplastic agent
Epidermal Growth Factor Receptor - tyrosine kinase inhibitor
Chemical Names
4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)chinazolin-4-amin (IUPAC)
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine (WHO)
Foreign Names
- Erlotinibum (Latin)
- Erlotinib (German)
- Erlotinib (French)
- Erlotinib (Spanish)
Generic Names
- Erlotinib Hydrochloride (OS: USAN)
- CP-358,774-01 (IS)
- NSC 718781 (IS)
- OSI-774 (IS: Osi)
- R-1415 (IS)
Brand Names
- Tarceva
Roche, Bulgaria; Roche, Colombia; Roche, Ecuador; Roche, Slovakia; Roche, Taiwan; Chugai, Japan; Genentech, United States; OSI, United States; Roche, Argentina; Roche, Austria; Roche, Australia; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Canada; Roche, Switzerland; Roche, China; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Spain; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Georgia; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Israel; Roche, Italy; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Poland; Roche, Portugal; Roche, Romania; Roche, Serbia; Roche, Sweden; Roche, Slovenia; Roche, Thailand; Roche, Venezuela; Roche RX, Singapore
International Drug Name Search
Glossary
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment